PB

Pooja Bhatia

Active Director Director DIN 10292279
DIN 10292279 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Pooja Bhatia

Data last updated:

Pooja Bhatia is a Director at Schon Pharmaceuticals Limited (since 2023). The company operates in Pharma. Schon Pharmaceuticals Limited reported revenue of ₹35.42 Cr (FY 2024).

DIN 10292279
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2023
Oldest Company Age 32 yrs
Largest company Schon Pharmaceuticals Limited · ₹35.42 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Schon Pharmaceuticals Limited U24231MP1994PLC007829
Director28 Aug 20231994₹35.42 Cr (FY 2024)Active

Board colleagues of Pooja Bhatia

Directorship timeline

Open interactive timeline →
Schon Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Pooja Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pooja Bhatia

Pooja Bhatia currently holds 1 directorship: Schon Pharmaceuticals Limited (Director, since 28 Aug 2023, revenue ₹35.42 Cr (FY 2024)).

Pooja Bhatia was first appointed on 28 Aug 2023 as Director at Schon Pharmaceuticals Limited.

The current boards of Pooja Bhatia's companies include Anil Bhatia (Schon Pharmaceuticals Limited), Prashant Singh (Schon Pharmaceuticals Limited), Sunil Bhatia (Schon Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available